1.5.3 Drugs affecting the immune response
Adalimumab
Amgevita 20mg/0.2ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Amgevita 20mg/0.4ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Amgevita 40mg/0.4ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Amgevita 40mg/0.4ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Amgevita 40mg/0.8ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Amgevita 40mg/0.8ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Amgevita 80mg/0.8ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Amgevita 80mg/0.8ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Imraldi 40mg/0.8ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
Imraldi 40mg/0.8ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
Azathioprine
Azathioprine 25mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
Azathioprine 50mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
Azathioprine 50mg/5ml oral suspension
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
Etrasimod
Velsipity 2mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Filgotinib
Jyseleca 200mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Infliximab
Remsima 100mg powder for concentrate for solution for infusion vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Remsima 120mg/1ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Mercaptopurine
Mercaptopurine 20mg/ml oral suspension
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
Mercaptopurine 50mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
Methotrexate
Methotrexate 10mg/5ml oral suspension
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
Methotrexate 2.5mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
Metoject PEN 10mg/0.2ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
Metoject PEN 12.5mg/0.25ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
Metoject PEN 15mg/0.3ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
Metoject PEN 17.5mg/0.35ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
Metoject PEN 20mg/0.4ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
Metoject PEN 22.5mg/0.45ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
Metoject PEN 25mg/0.5ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
Metoject PEN 7.5mg/0.15ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
Risankizumab
Skyrizi 360mg/2.4ml solution for injection cartridges
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
Skyrizi 600mg/10ml concentrate for solution for infusion vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
Tofacitinib
Xeljanz 10mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Xeljanz 1mg/ml oral solution
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Xeljanz 5mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Upadacitinib
Rinvoq 15mg modified-release tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Rinvoq 30mg modified-release tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Rinvoq 45mg modified-release tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Ustekinumab
Pyzchiva 130mg/26ml concentrate for solution for infusion vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
Pyzchiva 90mg/1ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
Wezenla 130mg/26ml concentrate for solution for infusion vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
Wezenla 90mg/1ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
Vedolizumab
Entyvio 108mg/0.68ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Entyvio 108mg/0.68ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Entyvio 300mg powder for concentrate for solution for infusion vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |